chrisvoncsefalvay/vaers-outcomes huggingface dataset:
A few days post vaccination, (10/17 or 10/18) my abdomen began to feel very itchy, I was scratching myself all day. My hyterectomy and laporoscopic scars began to inflame a few days later and I broke out into what looked like a heat rash above my pubic area and below my abdominal area. Rash developed on my lower abdomen and over the course of the week it spread to my underarms and under my breasts. My nipples, anus, eyes were also itchy. The rash became inflamed and severe itchiness and I created gouges and scratches all over my body, from my neck to on down to my ankles. My eczema on the lower, exterior of my legs, became incredibly inflamed and itchy. The rash was hot to touch, burned, was itchy and swollen. It hurt to wear a bra, underwear, and clothing. When I would have hot flashes, the rash became inflamed and ,blistered to the point of nausea. I thought I had an allergic reaction to millet in some bread but it was beyond any reaction I had ever had to food. My elbows were extremely itchy and I began to form lesions on my elbows and forearms and abdomen. I finally went to urgent care on 10/30/22 and was given an injection of dexthamethasone, a medrol dose pack, econozole cream, triamcinolone ointment.  It barely took the edge off for 12 hours. My eczema began to look like raw meat and fissures and gouges were deep. I had slight infections in the open wounds. I noticed redness on my lower right leg and then swelling in my left foot and ankle on November 17th around 9pm. I went to the ER because I feared cellulitis. After a full blood panel, the doctor felt I had a slight infection and prescribed 10 days of Cephalexin. On November 19, I noticed blistery rash spreading on my forearms and some tiny blisters on my right hand. I assumed it was a reaction to Keflex.  I had blistery rash on my abdomen and breasts. On November 22nd I saw the dermatologist, she was alarmed and gave me Kenalog injection and a medrol dose pack. My rash continued to spread and did not respond to steroids at all.  On November 28, I made the connection to the booster and my rash. Rash became hives all over arms and torso and thighs. crusty blistery rash. I saw my allergist and he diagnosed me with PLEVA (pityriasis lichenoides chronica). Dermatologist on 12/7/22 wrote rx for doxycycline and I will start tomorrow, 12/8/22.
Sharp, shooting, searing chest pain alongside flu-like symptoms (lethargy, body aches, headache, chills/fever).
Information has been received from a 35 year old male physician with asthma, sulfa allergy, history of small pox as a child, and no known illness at the time of vaccination who on an unspecified date was vaccinated with a third dose of varicella vaccine. Concomitant therapy included allopurinol and an unspecified "asthma inhaler." The physician reported that he has failed to seroconvert. Unspecified medical attention was sought. No further details were provided. Follow-up info received on 09/07/2001 revealed that on an unspecified date the pt received a fourth dose of varicella vaccine and still did not convert. "Negative response to varicella vaccine, no antibody titer yet" was reported. No further info is expecte.d
Local left upper arm reaction red, raised indurated 8cm x 8cm.  Patient having trouble moving arm.  Left arm painful with movement.
This spontaneous report as received from a licensed practical nurse refers to unspecified patients of unknown age and gender. the patients' pertinent medical history and drug reactions or allergies were not reported. On unknown dates in 2015 (reported as "after the first excursion reported on 19-JUN-2015"), the patients were vaccinated with improperly stored doses of VAQTA (dose, route of administration, lot# and expiry date were not reported). No improperly stored doses of VAQTA were administered after the second excursion reported on 16-JUL-2015. No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
I was diagnosed with Herpes soon after the vaccine; This is a spontaneous report from a contactable consumer (patient herself). A 22-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: FA7485, expiry date: unknown) via unspecified route of administration, in left arm on 19Jul2021 15:00 (age at vaccination: 22-years) as dose 1, single for COVID-19 immunisation. Patient was not pregnant at the time of vaccination. Patient did not take any other vaccines in four weeks and medications in two weeks. On 29Jul2021, patient was diagnosed with Herpes soon after the vaccine. AE resulted in Doctor or other healthcare professional office/clinic visit. Treatment was given due to the adverse event with acyclovir. Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. The outcome of event was not recovered. Follow-up attempts are completed. No further information is expected.
This spontaneous report was received from a physician via Pfizer (manufacturer control number: 2017211095), concerning a patient of unknown age and gender. The patient's concurrent conditions and medical history, as well as concomitant medications, were not provided. On an unknown date, the patient was vaccinated with PNEUMOVAX 23 (strength, dose, route, lot# and expiration date were unknown) for prophylaxis. On an unknown date, the patient experienced allergy to PNEUMOVAX 23 (allergy to vaccine). At the reporting time, the outcome of the event of allergy to vaccine was unknown. It was considered the event of allergy to vaccine to be related to PNEUMOVAX 23. Additional information has been requested.
Pt was sitting in the waiting room approximately 5 minutes after receiving the vaccine, when he said "I'm not feeling well. I feel dizzy.  I feel like I'm going to pass out".  We assisted him to a room and he laid down flat.  I also gave him an ice pack for his head.  Pt also c/o nausea at this point.  After 20 minutes, pt felt better and discharged from the clinic accompanied by his father.
Redness, swelling, painful to touch to right leg. Mother applied cool compress site with great improvement upon return to clinic for reevaluation.
patient who got the zostavax vaccine years ago, and has already gotten the first shot of shingrix; This spontaneous report was received from a male patient of unknown age regarding himself. The patient's concurrent conditions, medical history, historical drugs, drug allergies, concomitant medications were not reported. On an unknown date(reported as years ago), the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (strength, dose, lot# and expiry date were not reported), subcutaneously for prophylaxis. On an unknown date, it was reported that the patient had already gotten the first shot of zoster vaccine recombinant, adjuvanted (SHINGRIX). It was unknown why the patient received zoster vaccine recombinant, adjuvanted (SHINGRIX). The product quality complaint was not involved in the case. The outcome of the event was unknown. Causality assessment was not provided.
patient got Covid after the first dose of the vaccine; patient got Covid after the first dose of the vaccine; This is a spontaneous report from a Pfizer-sponsored program COVAX US Support from a contactable Nurse reporting for a patient. A patient of an unspecified age and gender received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunization.  Medical history and concomitant medications were not reported.  On an unknown date the patient got Covid after the first dose of the vaccine. The reporter was inquiring how long the patient should wait before getting a second dose. The clinical outcome of the patient got Covid after the first dose of the vaccine was unknown.     The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.; Sender's Comments: Based on available information, a possible contributory role of the subject product, BNT162B2 vaccine, cannot be excluded for the reported events of COVID-19 and suspected LOE.  There is limited information provided in this report.  This case will be reassessed once additional information is available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Left deltoid swollen, red, hot to touch. Left arm painful for 1 week, joint pain and constant body ache for 3 weeks. Weakness and fatigue.
Migraine immediately following first dose. Migraine, extreme fatigue, severe chills, sweats, full painful body aches, swollen underarm lymph nodes, and dizziness following second dose. Symptoms lasted approximately 36 hours, however I?m still experiencing swollen lymph nodes and a headache.
not feeling well; energy bolt; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (not feeling well) and ENERGY INCREASED (energy bolt) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (not feeling well) and ENERGY INCREASED (energy bolt). At the time of the report, VACCINATION COMPLICATION (not feeling well) and ENERGY INCREASED (energy bolt) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
This spontaneous report as received from a physician refers to a 12 month old patient. The patient's pertinent medical history was not reported. On 28-MAY-2014 the patient was vaccinated with PROQUAD (Merck). Concomitant medications were not reported. Other suspect therapies included VARIVAX (Merck). On 28-MAY-2014, patient was inadvertently administered both VARIVAX (Merck) and PROQUAD (Merck) at the same office visit, in different anatomical locations. No adverse effects were reported. The outcome of inadvertently administered both VARIVAX (Merck) and PROQUAD (Merck) at the same office visit and no adverse effects was unknown. Additional information has been requested.
This spontaneous report was received from a registered nurse regarding unspecified patients unknown age and gender. The patients' pertinent medical history, drug reactions or allergies and concomitant therapies were not reported. On unknown dates, the patients were vaccinated with improperly stored doses of VARIVAX lot # L042266 with expiration date 27-OCT-2017 or lot # L048462 with expiration date 02-DEC-2017 or lot #L048465 with expiration date 02-DEC-2017 or lot # M009765 with expiration date 23-FEB-2018 or lot # reported as M010485 with expiration date 01-MAR-2018 or lot # reported as M019643 with expiration date 20-APR-2018 (dose and route of administration were not reported). There was no adverse effect reported. Administered doses of vaccines experienced the temperature excursion of 11.5 degrees Fahrenheit for 3 hours and 54 minutes. Data logger was involved. The temperature was back in range. The previous excursions were the following:  15 degrees Fahrenheit during one hour and 20 minutes, 7 degrees Fahrenheit during two hours and 24.1 unspecified degrees during five hours and 41 minutes. This is one of several reports received from the same reporter. Additional information has been requested.
Patient was in office on 04/24/2018 for well visit, received her 2nd hep A during this visit. Mom called on 04/26/2018 to report a rash that appear that morning was informed by provider to give child BENADRYL 2.5 ml every 8 hours for rash and if not better to bring into office on 04/27/2018. Mom present in office this morning with child still having red rash that had not improved but spread even more. Provider is currently treating with hydroxyzine.
Diarrhea; This is a spontaneous report from a non-contactable consumer, the patient. A 39-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09Apr2021 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Concomitant medications included fexofenadine hydrochloride (ALLEGRA) and mefenamic acid (ADVIL) from an unknown date for unknown indication. The patient previously took aspirin and doxycycline, and experienced allergy to the medications. The patient did not receive any vaccination within four weeks prior to the COVID-19 vaccine. Previously, the patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 19Mar2021, (at the age of 39-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 11Apr2021, the patient experienced diarrhea 56 hours after vaccine. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event diarrhea was unknown at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.  Amendment: This follow-up report is being submitted to amend previously reported information: added country in patient tab and Vaccination Facility Country. Recoded Concomitant drug Advil
Transverse myelitis with progressive paraplegia. Pt developed numbness in left 4th and 5th toes 1-2 weeks after receiving the influenza vaccine in Nov 02. The numbness radiated down the lateral side of the left foot and the pt thought it was due to his boots. Within a few days he had similar symptoms in the right foot. The numbness progressed to the ankles in Dec 02, and then to the calves and by Jan 03 he experienced numbness from the knees down to the toes bilaterally. He had no associated pain, no tingling. He was able to walk but no longer able to run. He was in the process of changing duty, which delayed his seeking medical care. In March 03 he went to ER after the numbness progressed to the waist and he was occasionally losing his balance. He was seen by a PA and treated for gout. He followed up with the PA without improvement and was given a "stronger medicine" for gout. By the end of March he was seen in neurology and underwent "outpatient testing" but he did not receive the results. In mid-Apr 03 he awakened one morning and "my knees gave out from under me" and he fell to the floor. He was taken to the ER and was admitted to hospital for 2 weeks. He was diagnosed with Guillain-Barr syndrome and received IVIG on 4/18/03. He reports that he initially re-gained movement of the knees but that the improvement didn't last.  However, when he was transferred to rehabilitation hospital on May 1 03 he reports making steady improvement during the first few weeks and began to walk using a walker. However, a week before his scheduled discharge in mid-June he relapsed. Noteworthy medical history includes new onset cough and dry rash on the neck, chest, back, abdomen, arms and thighs in Feb 00 while in over-seas. He states the rash looked like ringworm and was treated with a cream after which it resolved. The cough was non-productive and continuous and was treated with inhalers. The cough lasted for 2 years the member reports. In Mar 00 intermittent hoarseness began. By Apr 00 the hoarseness became constant and on bro. Follow up on 10/28/2003: "Vaccine recipient did not recover from adverse events.  I have sent in an update on this patient already and we have determined that his condition is not vaccine-related.  He had neurologic complications of sarcoidosis.
Couple days after I received my vaccine, I started having paranoia, unusual thought and behavior and weird pattern recognitions. I would've probably needed to be hospitalized for psychosis if I wasn't surrounded by my loved ones.  Also the site of my injection has persistent pain tender to palpation
Chills and shivering from 9:00pm 1/12/21 until 01:00am 1/13/21, followed by fever of 101.2 and fatigue until 8:00pm 1/13/21.
Hives, itching, throat tightness--> pt took antihistamines and symptoms resolved. Pt sent to allergist who skin prick tested him to TwinRix and had positive skin test.
arm is killing; tired; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): NVSC2021US266562_NS (RA).  A 64 year-old female patient received bnt162b2 (BNT162B2, solution for injection), administration date 05Dec2021 (Batch/Lot number: unknown) at the age of 64 years as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 06Dec2021, outcome "unknown", described as "arm is killing"; FATIGUE (non-serious) with onset 06Dec2021, outcome "unknown", described as "tired".  The lot number for (BNT162B2), was not provided and will be requested during follow-up.
Splotching/ redness on primarily left side of neck, no treatment thus far, splotching/redness remains primarily on left side of neck.
Pt stated -Onset 12-16 hours post injection of shills, headache, body ache, joint pain and fatigue. The symptoms lasted a day and resolved.
cardiac arrest; This spontaneous case was reported by a consumer and describes the occurrence of CARDIAC ARREST (cardiac arrest) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CARDIAC ARREST (cardiac arrest) (seriousness criteria death and medically significant). The reported cause of death was Cardiac arrest. It is unknown if an autopsy was performed.            No concomitant medications were provided by the reporter. No treatment information was provided by the reporter.  This is a fatal case of cardiac arrest in a female, age unknown, who received mRNA-1273 on an unknown date. Cause of death was cardiac arrest. Very limited information has been provided at this time. Further information has been requested.; Sender's Comments: This is a fatal case of cardiac arrest in a female, age unknown, who received mRNA-1273 on an unknown date. Cause of death was cardiac arrest. Very limited information has been provided at this time. Further information has been requested.; Reported Cause(s) of Death: cardiac arrest
MULTIPLE MYLOMA!!!!!!    Im disgusted at the reponse of the government about this vaccine.  You had most americans vaccinated and many (TONS) are now experiencing CANCER, HEART ISSUES, NEUROPATHY.   THE GOVERNMENT SHOULD TAKE RESPONSIBLITY LIKE AT LAKE LE JEUNE
This spontaneous report was received from a pharmacy student referring to a female patient of unknown age. There was no information about the patient's pertinent medical history, concomitant medications and drug reactions or allergies provided. Approximately in May 2016 (reported as about a year ago), the patient was vaccinated with the first dose of VARIVAX (lot #, dose, route and site of administration and expiration date were not reported) for prevention of chicken pox. On an unknown date in May 2017 (reported as recently), the patient had unspecified titers drawn which exhibited that she was not protected from varicella virus. The patient did not receive the second dose of VARIVAX because she was trying to get pregnant and was undergoing in vitro fertilization (IVF) cycles. Reporter did not disclose whether potential difficulty with becoming pregnant initiated prior to or after receiving VARIVAX. The outcome of the events was unknown. Causality assessment was not provided. Additional information has been requested.
On March 17, 2021 I got a really bad sinus headache and my sinuses began hurting. This headache is still and issue. A few days later I got hot flashes at night and had disturbed sleep. The headache has at times caused ear ringing, but not all the time. March 23 I had chills at night. March 24th, I had chills all day. March 25 I still have the headache and my right arm hurts which is where I have lymphedema.
Information has been received from a physician concerning a male patient in his 60's (also reported as at least 60 years old) with a history of genital herpes who in approximately March 2011 ("about 1 or 2 months ago on an unspecified date"), was vaccinated with ZOSTAVAX (Merck) (lot # not reported). In 2011 the patient developed axillary lymphadenopathy within a few days after receiving the vaccine. The patient was seen by physician. It lasted several days and then resolved. The patient had been taking VALTREX for genital herpes but it was stopped prior to the patient receiving the vaccine. It was unknown how long VALTREX was held for. Additional information has been requested.
Entire upper arm swollen, hot and severe pain. I cannot sleep. Had high fever morning after. Horrible cognition the day after. Nausea still 4 days later. Pain, swelling and hot. Now bruised arm, literally.
This case was reported by a healthcare professional via sales representative and described the occurrence of pain during injection in a 78-year-old female subject who was vaccinated with BOOSTRIX (GlaxoSmithKline). On 11 September 2012 the subject received 1st dose of BOOSTRIX (.5 ml, unknown, right arm). On 11 September 2012, immediately after vaccination with BOOSTRIX, the subject experienced excruciating pain that began as soon as the vaccine was administered [pain during injection] and that has worsened. The pain and swelling affected her left arm from the shoulder down to her elbow [spreading pain], requiring the subject wear an arm sling. Because of the excruciating pain from shoulder to elbow necessitating the subject had to wear a sling. The healthcare professional considered the events were disabling. At the time of reporting the pain during injection, spreading pain and swelling were worse.
Had a low fever of 99.9 throughout the day, chills, severe headache, joint pain and weakness, dizziness, nausea.
Left arm swelling, pain, induration, tenderness and warmth in 7.5 cm x 6 cm area on left upper arm lateral aspect, also had nausea.
09/07/22 presents to ED for "knee injury". PMHx of "DM, Parkinson's, knee replacement"
I'm still experiencing left arm/shoulder upper pain around the injection area.  It's been over a month since I got the flu shot.  It hurts when I lift my arm or move it around.